Vertex Pharmaceuticals Incorporated (ETR: VX1)

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of €98.22 billion as of December 20, 2024. Its market cap has increased by 16.18% in one year.

• Market Cap: 98.22B
• Enterprise Value: 89.14B
• Revenue: 9.53B
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: €377.20

Market Cap Chart

Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 98.22B, an increase of 132,834.27%. That is a compound annual growth rate of 24.00%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	98.22B	3.54%
Dec 29, 2023	94.86B	36.76%
Dec 30, 2022	69.36B	41.28%
Dec 31, 2021	49.09B	-2.28%
Dec 31, 2020	50.24B	0.14%
Dec 31, 2019	50.17B	35.65%